article thumbnail

World AIDS Day 2023: New and Promising Treatments for HIV/AIDS

XTalks

More Investigational Therapies for HIV Are on the Way American Gene Technologies, a pioneering biotech company headquartered in Rockville, Maryland, has released promising results from its Phase I trial of AGT103-T, a gene therapy designed for individuals with chronic HIV disease.

article thumbnail

Oxford Nanopore makes stellar debut on UK stock market

pharmaphorum

The debut – raising upwards of £350 million from new shares – is the largest IPO for a UK biotech company since allergy drug specialist Circassia in 2014. Chief technology officer Clive Brown is also sitting on a £10 million stake.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

SARS-CoV-2 mutations do not appear to increase transmissibility

Scienmag

The analysis of virus genomes from over 46,000 people with COVID-19 from 99 countries is published today in Nature Communications. None of the mutations currently documented in the SARS-CoV-2 virus appear to increase its transmissibility in humans, according to a study led by UCL researchers.

Genome 58
article thumbnail

Fueling Growth Opportunities for Sustainable Agriculture

The Pharma Data

Gene editing investments advance agriculture with improved food quality, higher yield, and improved crop nutrition. Gene editing is the key to better solutions and greater choices for farmers and consumers around the world. In crop science that means a transformative opportunity to improve yield and simplify harvesting for farmers.

article thumbnail

Moderna’s COVID-19 vaccine trial; Freenome secures $270 M; CRISPR treats obesity in mice; Breast cancer research updates

Delveinsight

The phase 1 study that is being run by the National Institute of Allergy and Infectious Diseases tests three dose levels of the vaccine, mRNA-1273, given in two injections a month apart in 120 adults. Moderna showed robust phase 1 results for its COVID-19 vaccine in adults up to 55 last month.

article thumbnail

Nutrigenomics: The Future of Personalized Nutrition

Roots Analysis

According to a study, around 20,000 genes are present in the human body, all of which interact with the nutrients in the food, either directly or indirectly. Nutrigenomics is the science studying the relationship between human genome, nutrition and health.

Genome 40
article thumbnail

mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends

Roots Analysis

Messenger ribonucleic acid (mRNA) is a single-stranded molecule that is complementary to a gene’s DNA. Further, these can be used to activate both innate and adaptive immune system responses by silencing or upregulating immune-relevant genes.